Chromium

DIETARY_SUPPLEMENT6 trials

Sponsors

Griffin Hospital, University of California, San Francisco, Kasr El Aini Hospital, The Center for Applied Health Sciences, LLC, Beni-Suef University

Conditions

Blood GlucoseDiabetesImpaired Fasting GlucoseImpaired Glucose ToleranceInsulin ResistanceObesityPCOSPolycystic Ovary Syndrome

Phase 2

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

CompletedNCT00067626

Griffin HospitalImpaired Fasting Glucose, Impaired Glucose Tolerance, Insulin Resistance +2

Start: 2005-04-30End: 2009-03-31Target: 60Updated: 2010-10-15

Phase 3

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Not yet recruitingNCT06405243

Beni-Suef UniversityPolycystic Ovary Syndrome

Start: 2024-06-30End: 2024-12-31Target: 100Updated: 2024-05-08

Phase 4

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

Active, not recruitingNCT06709313

Fayoum UniversityDiabetes, Sacro Iliac Joint Pain

Start: 2024-06-03End: 2025-05-31Updated: 2024-11-29

Unknown Phase

Chromium and Insulin Resistance

CompletedNCT00846248

University of California, San FranciscoInsulin Resistance

Start: 2006-01-31End: 2011-07-31Updated: 2012-08-31

Effect of Chromium Supplementation on Intracytoplasmatic Sperm Injection (ICSI) Outcomes in Polycystic Ovary Syndrome Ladies

CompletedNCT03503201

Kasr El Aini HospitalPCOS

Start: 2018-04-23End: 2019-02-21Updated: 2019-03-29

Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life

CompletedNCT05573607

The Center for Applied Health Sciences, LLCBlood Glucose

Start: 2020-11-19End: 2021-07-08Updated: 2022-11-10

Related Papers

Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.

2012-11-307 citations